Surya Krupa Medicare

UrgoStart Contact is an innovative non-adhesive, non-occlusive flexible TLC-NOSF wound contact layer dressing. It is made of a polyester textile mesh coated with the TLC-NOSF technology.

NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.

Technologie Lipido-Colloïde – Nano-Oligo Saccharide Factor

INDICATIONS :

UrgoStart Contact is indicated for the treatment of chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers) and long-standing acute wounds.

BENEFITS:

• With its unique TLC-NOSF Healing Matrix (NOSF impregnated in a TLC healing matrix) UrgoStart is the only local treatment proven to reduce healing time and close wounds sooner
• The sooner the UrgoStart treatment range is initiated, the more effective it is.
• The UrgoStart Treatment range’s efficacy in healing significantly sooner has been demonstrated in the highest level of clinical studies (double-blind, randomised controlled trials) and through observational studies.
• Thanks to the TLC Technology, UrgoStart maintains a moist wound healing environment and allows pain-free & atraumatic removals.

Urgotul Silver is an antibacterial contact layer with TLC-Ag Technology (polyester mesh impregnated with hydrocolloid, petroleum jelly and silver particles)

Properties

- Broad spectrum antibacterial activity, including MRSA
- 99.9% removal of biofilms after 1 day
- Pain-free dressing changes
- Well-tolerated
- Moist wound-healing
- Clinically proven in a Randomised Controlled Trial

INDICATIONS

- Non to low exuding wounds, infected or at risk of infection
- Can be combined with an absorbent layer
- Can be used in cavity wounds

Method of use

- Add a secondary dressing - Secure with a retention bandage (K-Band, K-Lite)
- Can be left in place for up to 7 days

UrgoTul Absorb Border is indicated for the treatment of moderately to heavily exuding wounds in the epithelialisation stage (acute wounds such as burns, traumatic wounds, surgical wounds, postoperative wounds, and chronic wounds such as leg ulcers, pressure ulcers, diabetic foot ulcers).
The sacrum version is recommended for moderately to heavily exuding wounds located in the sacral area (sacral pressure ulcers…).

Highly absorbent adhesive foam sacrum dressing with soft-adherent TLC and silicone adhesive edges.

Features:-

·         Soft-adherent lipido-colloid layer combined with an absorbent foam pad and a highly absorbent layer

·         A vapour permeable waterproof outer film with silicone adhesive on the edges

·         Optimises wound healing

·         Painfree and atraumatic dressing changes¹

·         Promotes fibroblast proliferation

·         Absorbs moderate to heavy levels of exudate

UrgoStart Contact is an innovative non-adhesive, non-occlusive flexible TLC-NOSF wound contact layer dressing. It is made of a polyester textile mesh coated with the TLC-NOSF technology.

NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.

Technologie Lipido-Colloïde – Nano-Oligo Saccharide Factor

INDICATIONS :

UrgoStart Contact is indicated for the treatment of chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers) and long-standing acute wounds.

BENEFITS:

• With its unique TLC-NOSF Healing Matrix (NOSF impregnated in a TLC healing matrix) UrgoStart is the only local treatment proven to reduce healing time and close wounds sooner
• The sooner the UrgoStart treatment range is initiated, the more effective it is.
• The UrgoStart Treatment range’s efficacy in healing significantly sooner has been demonstrated in the highest level of clinical studies (double-blind, randomised controlled trials) and through observational studies.
• Thanks to the TLC Technology, UrgoStart maintains a moist wound healing environment and allows pain-free & atraumatic removals.

UrgoStart Contact is an innovative non-adhesive, non-occlusive flexible TLC-NOSF wound contact layer dressing. It is made of a polyester textile mesh coated with the TLC-NOSF technology.

NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.

Technologie Lipido-Colloïde – Nano-Oligo Saccharide Factor

INDICATIONS :

UrgoStart Contact is indicated for the treatment of chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers) and long-standing acute wounds.

BENEFITS:

• With its unique TLC-NOSF Healing Matrix (NOSF impregnated in a TLC healing matrix) UrgoStart is the only local treatment proven to reduce healing time and close wounds sooner
• The sooner the UrgoStart treatment range is initiated, the more effective it is.
• The UrgoStart Treatment range’s efficacy in healing significantly sooner has been demonstrated in the highest level of clinical studies (double-blind, randomised controlled trials) and through observational studies.
• Thanks to the TLC Technology, UrgoStart maintains a moist wound healing environment and allows pain-free & atraumatic removals.